Gastric acid normosecretion is not essential in the pathogenesis of mild erosive gastroesophageal reflux disease in relation to Helicobacter pylori status

Digestive Diseases and Sciences

Volumn 49, Issue 5, 2004, Pages 787-794

  Shimatani, Tomohiko ^a   Inoue, Masaki ^b   Harada, Nobue ^c   Horikawa, Yoko ^d   Nakamura, Masuo ^e   Tazuma, Susumu ^a  

^a HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

^b HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^c Tokyo Japan ^*  (Japan)

^d Eastern Examination Center   (Japan)

^e Wakasagi Medical Clinic   (Japan)

Author keywords

gastroesophageal reflux disease (GERD); intragastric pH; serum pepsinogens; Updated Sydney System

Indexed keywords

PEPSINOGEN;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; SEROLOGY; STOMACH ACID SECRETION; STOMACH PH;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GASTRIC ACID; GASTRIC ACIDITY DETERMINATION; GASTRIC MUCOSA; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC;

EID: 3042843779     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:DDAS.0000030090.84412.2a     Document Type: Article

References (47)

1. Asaka M, Kimura T, Kudo M, Takeda H, Mitani S, Miyazaki T, Miki K, Graham DY: Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology 102:760-766, 1992
2. Replogle ML, Kasumi W, Ishikawa KB, Yang SF, Juji T, Miki K, Kabat GC, Parsonnet J: Increased risk of Helicobacter pylori associated with birth in wartime and post-war Japan. Int J Epidemiol 25:210-214, 1996
3. Fujimoto K, Okamoto K, Iwakiri R: Epidemiology of gastroesophageal reflux disease. Nippon Naika Gakkai Zasshi 89:9-13, 2000 (in Japanese)
4. Takayasu H, Miwa T: Epidemiology of gastro-esophageal reflux disease. Nippon Rinsho 58:1886-1891, 2000 (in Japanese)
5. Dent J, Holloway RH, Toouli J, Dodds WJ: Mechanisms of lower oesophageal sphincter incompetence in patients with symptomatic gastrooesophageal reflux. Gut 29:1020-1028, 1988
6. Tytgat GN, Janssens J, Reynolds JC, Wienbeck M: Update on the pathophysiology and management of gastro-oesophageal reflux disease: the role of prokinetic therapy. Eur J Gastroenterol Hepatol 8:603-611, 1996
7. Stanciu C, Bennett JR: Oesophageal acid clearing: one factor in the production of reflux oesophagitis. Gut 15:852-857, 1974
8. Orlando RC: Pathophysiology of gastroesophageal reflux. Oesophageal epithelial resistance. In The Oesophagus. DO Castell (ed). New York, Little, Brown, 1992, pp 463-478
9. Safaie-Shirazi S, DenBesten L, Zike WL: Effect of bile salts on the ionic permeability of the esophageal mucosa and their role in the production of esophagitis. Gastroenterology 68:728-733, 1975
10. Jankowski J, Coghill G, Tregaskis B, Hopwood D, Wormsley KG: Epidermal growth factor in the oesophagus. Gut 33:1448-1453, 1992
11. Orlando RC, Bryson JC, Powell DW: Mechanisms of H+ injury in rabbit esophageal epithelium. Am J Physiol 246:G718-G724, 1984
12. Cunningham KM, Horowitz M, Riddell PS, Maddern GJ, Myers JC, Holloway RH, Wishart JM, Jamieson GG: Relations among autonomie nerve dysfunction, oesophageal motility, and gastric emptying in gastro-oesophageal reflux disease. Gut 32:1436-1440, 1991
13. Zhu H, Pace F, Sangaletti O, Bianchi Porro G: Gastric acid secretion and pattern of gastroesophageal reflux in patients with esophagitis and concomitant duodenal ulcer. A multivariate analysis of pathogenetic factors. Scand J Gastroenterol 28:387-392, 1993
14. Collen MJ, Johnson DA, Sheridan MJ: Basal acid output and gastric acid hypersecretion in gastroesophageal reflux disease. Correlation with ranitidine therapy. Dig Dis Sci 39:410-717, 1994
15. Collen MJ, Lewis JH, Benjamin SB: Gastric acid hypersecretion in refractory gastroesophageal reflux disease. Gastroenterology 98:54-61, 1994
16. Cadiot G, Bruhat A, Rigaud D, Coste T, Vuagnat A, Benyedder Y, Vallot T, Le Guludec D, Mignon M: Multivariate analysis of pathophysiological factors in reflux oesophagitis. Gut 40:167-174, 1997
17. Hirschowitz BI: A clitical analysis, with appropriate controls, of gastric acid and pepsin secretion in clinical esophagitis. Gastroenterology 101:1149-1158, 1991
18. Kimura K, Takemoto T: Endoscopic atrophy border. Endoscopy 1:1-3, 1969
19. Satoh K, Kimura K, Taniguchi Y, Yoshida Y, Kihira K, Takimoto T, Kawata H, Saifuku K, Ido K, Takemoto T, Ota Y, Tada M, Karita M, Sakaki N, Hoshihara Y: Distribution of inflammation and atrophy in the stomach of Helicobacter pylori-positive and -negative patients with chronic gastritis. Am J Gastroenterol 91:963-969, 1996
20. Ito S, Azuma T, Murakita H, Hirai M, Miyaji H, Ito Y, Ohtaki Y, Yamazaki Y, Kuriyama M, Keida Y, Kohli Y: Profile of Helicobacter pylori cytotoxin derived from two areas of Japan with different prevalence of atrophic gastritis. Gut 39:800-806, 1996
21. Dixon MF, Genta RM, Yardley JH, Correa P: Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 20:1161-1181, 1996
22. Miki K, Ichinose M, Shimizu A, Huang SC, Oka H, Furihata C, Matsushima T, Takahashi K: Serum pepsinogens as a screening test of extensive chronic gastritis. Gastroenterol Jpn 22:133-141, 1987
23. Levi S, Beardshall K, Haddad G, Playford R, Ghosh P, Calam J: Campylobacter pylori and duodenal ulcers: the gastrin link. Lancet 27:1167-1168, 1989
24. Calam J: The somatostatin-gastrin link of Helicobacter pylori infection. Ann Med 27:569-573, 1995
25. Konturek PC, Konturek SJ: Role of Helicobacter pylori infection in gastroduodenal secretion and in pathogenesis of peptic ulcer and gastritis. J Physiol Pharmacol 45:333-350, 1994
26. Calam J: Pathogenic mechanisms. Baillieres Clin Gastroenterol 9:487-506, 1995
27. Graham DY, Opekun A, Lew GM, Evans DJ Jr, Klein PD, Evans DG: Ablation of exaggerated meal-stimulated gastrin release in duodenal ulcer patients after clearance of Helicobacter (Campylobacter) pylori infection. Am J Gastroenterol 85:394-398, 1990
28. El-Omar E, Penman I, Dorrian CA, Ardill JE, McColl KE: Eradicating Helicobacter pylori infection lowers gastrin mediated acid secretion by two thirds in patients with duodenal ulcer. Gut 34:1060-1065, 1994
29. Levi S, Beardshall K, Swift I, Foulkes W, Playford R, Ghosh P, Calam J: Antral Helicobacter pylori, hypergastrinaemia, and duodenal ulcers: effect of eradicating the organism. BMJ 299:1504-1505, 1989
30. Courillon-Mallet A, Launay JM, Roucayrol AM, Callebert J, Emond JP, Tabuteau F, Cattan D: Helicobacter pylori infection: Physiopathologic implications of N-α-methyl histamine. Gastroenterology 108:95-966, 1995
31. Noach LA, Bosma NB, Jansen J, Hoek FJ, van Deventer SJ, Tytgat GN: Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection. Scand J Gastroenterol 29:425-429, 1994
32. Crabtree JE, Shallcross TM, Heatley RV, Wyatt JI: Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut 32:1473-1477, 1991
33. 14C]-aminopyrine accumulation by isolated canine parietal cells. J Pharmacol Exp Ther 270:440-445, 1994
34. Kondo S, Shinomura Y, Kanayama S, Kawabata S, Miyazaki Y, Imamura I, Fukui H, Matsuzawa Y: Interleukin-1 beta inhibits gastric histamine secretion and synthesis in the rat. Am J Physiol 267:G966-G971, 1994
35. Feldman M, Cryer B, McArthur KE, Huet BA, Lee E: Effects of aging and gastritis on gastric acid and pepsin secretion in humans: a prospective study. Gastroenterology 110:1043-1052, 1996
36. Hurwitz A, Brady DA, Schaal SE, Samloff IM, Dedon J, Ruhl CE: Gastric acidity in older adults. JAMA 278:659-662, 1997
37. Trey G, Marks IN, Louw JA, Jaskiewicz K, Sipponen P, Novis BH, Bank S, Tigler-Wybrandi NA: Changes in acid secretion over the years. A 30-year longitudinal study. J Clin Gastroenterol 25:499-502, 1997
38. Haruma K, Kamada T, Kawaguchi H, Okamoto S, Yoshihara M, Sumii K, Inoue M, Kishimoto S, Kajiyama G, Miyoshi A: Effect of age and Helicobacter pylori infection on gastric acid secretion. J Gastroenterol Hepatol 15:277-283, 2000
39. Ohara S, Sekine H, Iijima K, Moriyama S, Nakayama Y, Kinpara T, Kato K, Asaki S, Katakura T, Ikeda T, Toyota T: Gastric mucosal atrophy and prevalence of Helicobacter pylori in reflux esophagitis of the elderly. Nippon Shokakibyo Gakkai Zasshi 93:235-239, 1996 (in Japanese with English abstract)
40. Goedhard JG, Biemond I, Giliams JP, Pals G, Kreuning J: Serum pepsinogen I levels: assessment of gastric acid secretion? Prog Clin Biol Res 173:139-146, 1985
41. Yamaji Y, Mitsushima T, Ikuma H, Okamoto M, Yoshida H, Kawabe T, Shiratori Y, Saito K, Yokouchi K, Omata M: Inverse background of Helicobacter pylori antibody and pepsinogen in reflux oesophagitis compared with gastric cancer: analysis of 5732 Japanese subjects. Gut 49:335-340, 2001
42. Manes G, Mosca S, Laccetti M, Lioniello M, Balzano A: Helicobacter pylori infection, pattern of gastritis, and symptoms in erosive and nonerosive gastroesophageal reflux disease. Scand J Gastroenterol 34:658-662, 1999
43. Voutilainen M, Sipponen P, Mecklin JP, Juhola M, Farkkila M: Gastroesophageal reflux disease: prevalence, clinical, endoscopic and histopathological findings in 1,128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms. Digestion 61:6-13, 2000
44. Haruma K, Hamada H, Mihara M, Kamada T, Yoshihara M, Sumii K, Kajiyama G, Kawanishi M: Negative association between Helicobacter pylori infection and reflux esophagitis in older patients: case-control study in Japan. Helicobacter 5:24-29, 2000
45. El-Serag HB, Sonnenberg A, Jamal MM, Inadomi JM, Crooks LA, Feddersen RM: Corpus gastritis is protective against reflux oesophagitis. Gut 45:181-185, 1999
46. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, Lanyon G, Martin M, Fraumeni JF Jr, Rabkin CS: Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404:398-402, 2000
47. Furuta T, El-Omar EM, Xiao F, Shirai N, Takashima M, Sugimura H, Sugimurra H: Interleukin 1 beta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. Gastroenterology 123:92-105, 2002